AUGO (AUGO) holder plans to sell 10,000 shares after prior 60,000 sale

Rhea-AI Filing Summary

AUGO shareholder Joao Kleber dos Santos Cardoso filed a notice to sell up to 10,000 shares of common stock through Merrill Lynch on or about August 7, 2026 on Nasdaq, with an aggregate market value of $700,291.98. The shares were acquired via stock option exercise on December 17, 2024 for cash. In the past three months, Cardoso sold 60,000 shares of common stock on June 30, 2026 for $3,717,152.28.

Key Figures

Planned shares to be sold: 10,000 shares Aggregate market value of planned sale: $700,291.98 Recent shares sold: 60,000 shares +2 more

5 metrics

Planned shares to be sold 10,000 shares Common stock planned for sale on or about August 7, 2026

Aggregate market value of planned sale $700,291.98 Estimated value of 10,000 shares of common stock

Recent shares sold 60,000 shares Common stock sold on June 30, 2026 in the past three months

Proceeds from recent sale $3,717,152.28 Total amount received for 60,000 shares sold on June 30, 2026

Acquisition date of shares December 17, 2024 Date the 10,000 shares were acquired via stock option exercise

Key Terms

Form 144, stock option exercise, aggregate market value, Nasdaq

4 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

stock option exercise financial

"Common Stocks | 12/17/2024 | Stock option exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"Common Stock | Merrill Lynch... | 10000 | 700291.98"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Nasdaq market

"83789224 | 08/07/2026 | Nasdaq 144: Securities To Be Sold"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 04:06 PM Accepted by SEC EDGAR 08/07/2026 - 04:05 PM Learn about SEC filing dates

FAQ

What sale of AUGO stock is disclosed in this Form 144 notice?

The filing discloses a planned sale of up to 10,000 shares of AUGO common stock, with an aggregate market value of $700,291.98, to be sold on or about August 7, 2026 through Merrill Lynch on Nasdaq.

How were the AUGO shares to be sold on August 7, 2026 acquired?

The 10,000 shares of AUGO common stock planned for sale were acquired on December 17, 2024 via a stock option exercise from the issuer, with the exercise price paid in cash.

What AUGO stock sales has Joao Kleber dos Santos Cardoso made recently?

In the past three months, Joao Kleber dos Santos Cardoso sold 60,000 shares of AUGO common stock on June 30, 2026 for total proceeds of $3,717,152.28, as reported in the filing.

Which broker is handling the planned AUGO stock sale in this Form 144?

The planned sale of up to 10,000 AUGO shares is to be handled by Merrill Lynch, Pierce, Fenner and Smith, located at 19495 Biscayne Blvd, Suite 700, Aventura, FL 33180, with trading expected on Nasdaq.

What exchange is specified for the planned AUGO share sale?

The notice specifies that the 10,000 AUGO common shares covered by this Form 144 are to be sold on the Nasdaq market, with an indicated aggregate market value of $700,291.98 as of the planned sale date.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch, Pierce, Fenner and Smith 19495 Biscayne Blvd Suite 700 Aventura FL 33180	10000	700291.98	83789224	08/07/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stocks	12/17/2024	Stock option exercise	Issuer			10000	12/17/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Joao Kleber dos Santos Cardoso 3390 Mary St Suite 116 Coconut Grove FL 33133	Common Stock	06/30/2026	60000	3717152.28

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)